Literature DB >> 8035808

Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site.

I C Oliveira1, N Mukaida, K Matsushima, J Vilcek.   

Abstract

The cytokine interleukin-8 (IL-8) is an important mediator of neutrophil, lymphocyte, and basophil chemotaxis and activation. Earlier we demonstrated that beta interferon (IFN-beta) can inhibit tumor necrosis factor (TNF)-induced IL-8 gene expression at the transcriptional level, apparently by a novel mechanism. To define the cis-acting elements and trans-acting factors involved in this inhibition, DNA constructs containing portions of the 5'-flanking region of the IL-8 gene were linked to the chloramphenicol acetyltransferase (CAT) reporter gene and transfected into human diploid FS-4 fibroblasts. The region spanning positions -98 to +44 was sufficient to confer both inducibility by TNF and inhibition by simultaneous treatment with IFN-beta. Inhibition of TNF- or IL-1-induced CAT activity by IFN-beta or IFN-alpha was also observed when a DNA fragment containing only the NF-IL-6 and NF-kappa B sites (positions -94 to -70) was placed upstream of the homologous or a heterologous minimal promoter. A construct containing three copies of the NF-kappa B element in front of the CAT gene also was inducible by TNF, and this stimulatory effect too was inhibited by IFN-beta, indicating that the NF-kappa B element is sufficient to confer inhibition by IFN-beta. This inhibitory effect was specific for the NF-kappa B site of the IL-8 gene since it was less marked with constructs containing three copies of the NF-kappa B site from the HLA-B7 gene. Gel shift assays with a probe containing the NF-kappa B and NF-IL-6 binding sites of the IL-8 gene (positions -101 to -63) showed that IFN-beta treatment did not block the activation of NF-kappa B proteins or their ability to bind to the NF-kappa B site. However, nuclear extracts from cells treated with TNF in the presence of IFN-beta gave rise to an additional band that appears to contain protein components from the NF-kappa B and NF-IL-6 families. NF-kappa B site-mediated suppression of IL-8 gene expression by IFN-beta represents a hitherto unknown mechanism and target of IFN action.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035808      PMCID: PMC359049          DOI: 10.1128/mcb.14.8.5300-5308.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.

Authors:  B Luckow; G Schütz
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

2.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  Proposed NF-kappa B/I kappa B family nomenclature.

Authors:  G J Nabel; I M Verma
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

4.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8.

Authors:  N Mukaida; M Shiroo; K Matsushima
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

6.  Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction.

Authors:  B Stein; P C Cogswell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

7.  Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells.

Authors:  M J Aman; G Rudolf; J Goldschmitt; W E Aulitzky; C Lam; C Huber; C Peschel
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

8.  Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.

Authors:  T Matsusaka; K Fujikawa; Y Nishio; N Mukaida; K Matsushima; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.

Authors:  B Stein; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

10.  Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes.

Authors:  J W Lowenthal; D W Ballard; E Böhnlein; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  22 in total

1.  Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter.

Authors:  L F Lee; J S Haskill; N Mukaida; K Matsushima; J P Ting
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  IFNalpha/beta promotes cell survival by activating NF-kappa B.

Authors:  C H Yang; A Murti; S R Pfeffer; L Basu; J G Kim; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway.

Authors:  Chuan He Yang; Aruna Murti; William J Valentine; Ziyun Du; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2005-05-09       Impact factor: 5.157

4.  Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B.

Authors:  J Anrather; V Csizmadia; C Brostjan; M P Soares; F H Bach; H Winkler
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

5.  Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter.

Authors:  P Ghersa; J Whelan; Y Cambet; J F DeLamarter; R Hooft van Huijsduijnen
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

Review 6.  Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression.

Authors:  Thomas Hamilton; Michael Novotny; Paul J Pavicic; Tomasz Herjan; Justin Hartupee; Dongxu Sun; Chenyang Zhao; Shyamasree Datta
Journal:  Cytokine       Date:  2010-04-28       Impact factor: 3.861

7.  Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.

Authors:  Chuan He Yang; Aruna Murti; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2005-07-11       Impact factor: 5.157

8.  Regulation of interleukin 12 p40 expression through an NF-kappa B half-site.

Authors:  T L Murphy; M G Cleveland; P Kulesza; J Magram; K M Murphy
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

9.  Cold shock domain proteins repress transcription from the GM-CSF promoter.

Authors:  L S Coles; P Diamond; F Occhiodoro; M A Vadas; M F Shannon
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

10.  Lipopolysaccharide-induced interleukin-8 gene expression in human granulocytes: transcriptional inhibition by interferon-gamma.

Authors:  M A Cassatella; S Gasperini; F Calzetti; P P McDonald; G Trinchieri
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.